Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

The transforming growth factor beta (TGF-beta) type II receptor (T beta R-II) is a transmembrane serine/threonine kinase that contains two inserts in the kinase region and a serine/threonine-rich C-terminal extension. T beta R-II is required for TGF-beta binding to the type I receptor, with which it forms a heteromeric receptor complex, and its kinase activity is required for signaling by this complex. We investigated the role of various cytoplasmic regions in T beta R-II by altering or deleting these regions and determining the signaling activity of the resulting products in cell lines made resistant to TGF-beta by inactivation of the endogenous T beta R-II. TGF-beta binding to receptor I and responsiveness to TGF-beta in these cells can be restored by transfection of wild-type T beta R-II. Using this system, we show that the kinase insert 1 and the C-terminal tail of T beta R-II, in contrast to the corresponding regions in most tyrosine kinase receptors, are not essential to specify ligand-induced responses. Insert 2 is necessary to support the catalytic activity of the receptor kinase, and its deletion yields a receptor that is unable to mediate any of the responses tested. However, substitution of this insert with insert 2 from the activin receptor, ActR-IIB, does not diminish the ability of T beta R-II to elicit these responses. A truncated T beta R-II lacking the cytoplasmic domain still binds TGF-beta, supports ligand binding to receptor I, and forms a complex with this receptor. However, TGF-beta binding to receptor I facilitated by this truncated T beta R-II fails to inhibit cell proliferation, activate extracellular matrix protein production, or activate transcription from a promoter containing TGF-beta-responsive elements. We conclude that the transcriptional and antiproliferative responses to TGF-beta require both components of a heteromeric receptor complex that differs from tyrosine kinase receptors in its mode of signaling.

[1]  R. Derynck,et al.  Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. , 1993, Science.

[2]  R. Derynck,et al.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. , 1993, Science.

[3]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[4]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.

[5]  H. Lodish,et al.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases. , 1993, Trends in cell biology.

[6]  M. Laiho,et al.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. , 1987, The Journal of biological chemistry.

[7]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[8]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[9]  L. Mathews,et al.  Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. , 1992, Science.

[10]  J. Massagué [17] Identification of receptor for type-β transforming growth factor , 1987 .

[11]  J. Massagué,et al.  The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors , 1987, Cell.

[12]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[13]  D. Riddle,et al.  The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development , 1993, Nature.

[14]  J. Massagué,et al.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.

[15]  L. Williams Signal transduction by the platelet-derived growth factor receptor. , 1989, Science.

[16]  L. Mathews,et al.  Expression cloning of an activin receptor, a predicted transmembrane serine kinase , 1991, Cell.

[17]  T. Brand,et al.  A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. , 1993, The Journal of biological chemistry.

[18]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[19]  J. Zheng,et al.  Structural framework for the protein kinase family. , 1992, Annual review of cell biology.

[20]  J. Pouysségur,et al.  Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk. , 1992, Molecular biology of the cell.

[21]  J. Massagué,et al.  Identification of a Drosophila activin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Massagué Receptors for the TGF-β family , 1992, Cell.

[23]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[24]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[25]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[26]  Andrew R. Cherenson,et al.  The structure of an antigenic determinant in a protein , 1984, Cell.

[27]  J. Massagué,et al.  Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors , 1992, Cell.

[28]  D. Riddle,et al.  daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase , 1990, Cell.

[29]  H. Moses,et al.  Transforming growth factors and the regulation of cell proliferation. , 1990, European journal of biochemistry.

[30]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.